Question 1

Labelled or label-free quantification?

Accepted Answer

Chemical tags let several samples be combined and measured together, which removes much run-to-run variation but caps how many samples share a batch and can compress observed differences. Label-free scales to hundreds of samples with more variability. Cohort size and the expected effect usually settle the choice.

Question 2

Why does the abundance range in blood cause such trouble?

Accepted Answer

A handful of proteins make up most of the material, burying anything tissue-derived far below them. Removing the abundant fraction, fractionating, or enriching a subclass such as released vesicles all help, though each step adds variability and can carry away bound partners. Report the approach and its reproducibility.

Question 3

How should missing values be treated?

Accepted Answer

Distinguish values absent because abundance fell below detection from those missing for unrelated reasons, since the first is informative and the second is not. Use approaches suited to each rather than one method throughout, state the proportion missing per protein, and check that conclusions survive a different reasonable choice.

Question 4

What does data-independent acquisition change?

Accepted Answer

Fragmenting everything within defined windows rather than selecting peaks in the moment gives far more consistent measurement across many samples and fewer gaps, at the cost of more complex spectra requiring library or library-free analysis. For large cohorts the improvement in completeness usually outweighs the analytical difficulty.

Question 5

How is protein-level inference handled honestly?

Accepted Answer

Many peptides map to more than one protein, so grouping rules determine what is reported. State the rules used, distinguish proteins identified by unique sequence from grouped entries, and remember that error control applied to peptides does not transfer to protein-level lists without separate estimation.

Question 6

How are batch and run order managed?

Accepted Answer

Randomise clinical groups across batches and injection sequence so that neither aligns with the comparison of interest, include pooled reference samples at intervals to track performance, and include batch in the statistical model. Column changes and instrument maintenance during a study should be recorded and treated as batch boundaries.

Question 7

What does verification require?

Accepted Answer

Targeted measurement of the candidate set with heavy-labelled internal standards, in samples never used for discovery, giving absolute or ratio-based figures with known precision. Report how many discovery candidates survived, since attrition at this step is high and describing it plainly strengthens the work.

Biotechnology

Biotechnology

Research Frontiers in Quantitative Proteomics Biomarker Discovery